Literature DB >> 21661047

Genomewide linkage study of modifiers of LRRK2-related Parkinson's disease.

Jeanne C Latourelle1, Audrey E Hendricks, Nathan Pankratz, Jemma B Wilk, Cheryl Halter, William C Nichols, James F Gusella, Anita L Destefano, Richard H Myers, Tatiana Foroud.   

Abstract

Mutations in the leucine-rich repeat kinase 2 gene, located at 12q12, are the most common known genetic causes of Parkinson's disease. Studies of leucine-rich repeat kinase 2 mutation carriers have shown incomplete and age-dependent penetrance, and previous studies have suggested that inherited susceptibility factors may modify the penetrance of leucine-rich repeat kinase 2 mutations. Genomewide linkage to age of onset of leucine-rich repeat kinase 2-related Parkinson's disease was evaluated in a sample of 113 leucine-rich repeat kinase 2 mutation carriers from 64 families using single-nucleotide polymorphism data from the Illumina HumanCNV370 genotyping array. Association between onset age and single-nucleotide polymorphisms under suggestive linkage peaks was also evaluated. The top logarithmic odds score for onset age (logarithmic odds score = 2.43) was in the chromosome 1q32.1 region. Moderate linkage to onset was also identified at 16q12.1 (logarithmic odds score = 1.58). Examination of single-nucleotide polymorphism association to Parkinson's disease onset under the linkage peaks revealed no statistically significant single-nucleotide polymorphism associations. The 2 novel genomic regions identified may harbor modifiers of leucine-rich repeat kinase 2-related Parkinson's disease onset age or penetrance, and further study of these regions may provide important insight into leucine-rich repeat kinase 2-related Parkinson's disease.
Copyright © 2011 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21661047      PMCID: PMC3346677          DOI: 10.1002/mds.23781

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  35 in total

1.  G2019S LRRK2 mutation in French and North African families with Parkinson's disease.

Authors:  Suzanne Lesage; Pablo Ibanez; Ebba Lohmann; Pierre Pollak; François Tison; Myriem Tazir; Anne-Louise Leutenegger; Joao Guimaraes; Anne-Marie Bonnet; Yves Agid; Alexandra Dürr; Alexis Brice
Journal:  Ann Neurol       Date:  2005-11       Impact factor: 10.422

2.  Handling marker-marker linkage disequilibrium: pedigree analysis with clustered markers.

Authors:  Gonçalo R Abecasis; Janis E Wigginton
Journal:  Am J Hum Genet       Date:  2005-09-20       Impact factor: 11.025

3.  Principal components analysis corrects for stratification in genome-wide association studies.

Authors:  Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich
Journal:  Nat Genet       Date:  2006-07-23       Impact factor: 38.330

Review 4.  Whole-genome genotyping.

Authors:  Kevin L Gunderson; Frank J Steemers; Hongi Ren; Pauline Ng; Lixin Zhou; Chan Tsan; Weihua Chang; Dave Bullis; Joe Musmacker; Christine King; Lori L Lebruska; David Barker; Arnold Oliphant; Kenneth M Kuhn; Richard Shen
Journal:  Methods Enzymol       Date:  2006       Impact factor: 1.600

5.  Frequency of LRRK2 mutations in early- and late-onset Parkinson disease.

Authors:  L N Clark; Y Wang; E Karlins; L Saito; H Mejia-Santana; J Harris; E D Louis; L J Cote; H Andrews; S Fahn; C Waters; B Ford; S Frucht; R Ottman; K Marder
Journal:  Neurology       Date:  2006-10-18       Impact factor: 9.910

Review 6.  Pathogenic mutations in Parkinson disease.

Authors:  Eng-King Tan; Lisa M Skipper
Journal:  Hum Mutat       Date:  2007-07       Impact factor: 4.878

7.  Mutations in LRRK2 other than G2019S are rare in a north American-based sample of familial Parkinson's disease.

Authors:  Nathan Pankratz; Michael W Pauciulo; Veronika E Elsaesser; Diane K Marek; Cheryl A Halter; Alice Rudolph; Clifford W Shults; Tatiana Foroud; William C Nichols
Journal:  Mov Disord       Date:  2006-12       Impact factor: 10.338

8.  High prevalence of LRRK2 mutations in familial and sporadic Parkinson's disease in Portugal.

Authors:  Joaquim J Ferreira; Leonor Correia Guedes; Mário Miguel Rosa; Miguel Coelho; Marina van Doeselaar; Dorothea Schweiger; Alessio Di Fonzo; Ben A Oostra; Cristina Sampaio; Vincenzo Bonifati
Journal:  Mov Disord       Date:  2007-06-15       Impact factor: 10.338

9.  Evaluation of LRRK2 G2019S penetrance: relevance for genetic counseling in Parkinson disease.

Authors:  S Goldwurm; M Zini; L Mariani; S Tesei; R Miceli; F Sironi; M Clementi; V Bonifati; G Pezzoli
Journal:  Neurology       Date:  2007-01-10       Impact factor: 9.910

10.  Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study.

Authors:  Mei Sun; Jeanne C Latourelle; G Frederick Wooten; Mark F Lew; Christine Klein; Holly A Shill; Lawrence I Golbe; Margery H Mark; Brad A Racette; Joel S Perlmutter; Abbas Parsian; Mark Guttman; Garth Nicholson; Gang Xu; Jemma B Wilk; Marie H Saint-Hilaire; Anita L DeStefano; Ranjana Prakash; Sally Williamson; Oksana Suchowersky; Nancy Labelle; John H Growdon; Carlos Singer; Ray L Watts; Stefano Goldwurm; Gianni Pezzoli; Kenneth B Baker; Peter P Pramstaller; David J Burn; Patrick F Chinnery; Scott Sherman; Peter Vieregge; Irene Litvan; Tammy Gillis; Marcy E MacDonald; Richard H Myers; James F Gusella
Journal:  Arch Neurol       Date:  2006-06
View more
  2 in total

1.  RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson's disease risk.

Authors:  David A MacLeod; Herve Rhinn; Tomoki Kuwahara; Ari Zolin; Gilbert Di Paolo; Brian D McCabe; Brian D MacCabe; Karen S Marder; Lawrence S Honig; Lorraine N Clark; Scott A Small; Asa Abeliovich
Journal:  Neuron       Date:  2013-02-06       Impact factor: 17.173

2.  Key issues in essential tremor genetics research: Where are we now and how can we move forward?

Authors:  Claudia M Testa
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2013-01-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.